Zimmer Biomet Holdings, Inc. vs Eli Lilly & Co.
ZBH vs LLY — side-by-side comparison from reported financials. ZBH leads 4, LLY leads 7 of 11 comparable metrics.
Zimmer Biomet Holdings, Inc.
ZBH · Healthcare
$89.00+0.14%Mixed
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
| Metric | ZBH | LLY |
|---|---|---|
| Price | $89.00 | $1 177.20 |
| Market cap | $17.0B | $1.05T |
| Revenue (TTM) | $8.51B | $79.7B |
| Revenue growth | +5.8% | +31.7% |
| Net margin | 9.5% | 33.5% |
| Free cash flow | $1.52B | $18.2B |
| Net cash (debt) | ($6.34B) | ($35.2B) |
| 1-year price return | -8.6% | +37.6% |
| P/E | 21.5 | 41.6 |
| P/E vs own history (cheap-side %) | 96% | 88% |
| Dividend yield | 1.09% | 0.52% |
| Return on equity | 6% | 93% |
| Altman Z-score | 2.15 | 7.10 |
| CV checks passed | 11 of 11 | 11 of 11 |
| Employees | 17,000 | 50,000 |
Full résumé-style profiles: ZBH CV · LLY CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.